Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
Fast Track application is based on positive data in NSCLC HER2 exon 20 insertion mutations in previously treated patients
Positive Results for Cohort 2 of ZENITH20 clinical trial published in Journal of Clinical Oncology
HENDERSON,...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news
More News: Cancer & Oncology | Clinical Trials | Drugs & Pharmacology | HER2 | New Drug Applications | Non-Small Cell Lung Cancer